Evaluation of the Alliance HPLC System to Separate Budesonide Epimers following the USP Compendial Method

Significance of the Topic

Budesonide epimer separation plays a vital role in quality control of corticosteroid pharmaceuticals, ensuring product purity, safety and therapeutic efficacy in asthma, rhinitis and inflammatory bowel disease formulations.

Objectives and Study Overview

This study assessed the performance of the Waters Alliance HPLC System in meeting USP monograph requirements for separating the C-22S and C-22R epimers of budesonide under compendial conditions.

Methodology and Sample Preparation

• Column: Waters XBridge C18, 4.6×150 mm, 5 µm (L1 chemistry).
• Mobile phase: 23 mM phosphate buffer and acetonitrile, pH 3.2.
• Detection: UV at 254 nm.
• Sample concentration: adjusted from 0.5 mg/mL API to 12.8 µg/mL in final formulation to ensure complete dissolution of excipient matrix.
• Replicates: six injections of standard and sample solutions.

Instrumentation

• Waters Alliance HPLC System equipped with 2489 UV/Vis Detector.

Main Results and Discussion

The system easily satisfied USP criteria:

• Resolution between epimers ≥ 1.5: achieved 2.03.
• Plate count (epimer B) ≥ 5500: measured 7962 theoretical plates.
• Relative retention time (epimer A/B) = 1.1.
• Area repeatability (RSD) ≤ 2.0%: 0.28% (B), 0.39% (A).
• Retention time repeatability (RSD) ≤ 2.0%: 0.03% (B), 0.02% (A).

The results demonstrate robust mixing, precise pumping and reliable detection, delivering reproducible chromatograms under compendial conditions.

Benefits and Practical Applications

The Alliance HPLC System offers high precision and reliability for routine compendial testing in pharmaceutical QA/QC laboratories, enabling confident monitoring of budesonide epimer purity in drug products.

Future Trends and Applications

Advancements in column chemistries, integrated software for method development, increased automation, coupling with mass spectrometry and adoption of greener solvents are expected to further enhance HPLC performance and sustainability in pharmaceutical analysis.

Conclusion

The study confirms that the Waters Alliance HPLC System successfully meets USP monograph requirements for budesonide epimer separation, providing a robust and precise platform suitable for quality control laboratories.

Reference

• Chavali A. Evaluation of the Alliance HPLC System to Separate Budesonide Epimers following the USP Compendial Method. Waters Corporation Application Note, January 2013.